The most common adverse events associated with long-term denosumab use were back, musculoskeletal, or extremity pain, hypercholesterolemia, and cystis.
The most important predictor for use of osteoporosis care was receiving primary care services within 6 months following hip fracture.
Neither DXA-visceral adipose tissue nor android-gynoid fat mass ratios were associated with atherosclerotic cardiovascular disease events.
Researchers evaluated trabecular bone scores in more than 100 women during either "legs up" or "legs down" dual energy x-ray absorptiometry scans.
Using dual-energy X-ray absorptiometry for bone age assessment complements traditional radiologic assessment.
Fragility fracture risk increased with older age and decreased with higher bone mineral density in patients with type 1 diabetes.
Researchers compared the efficacy of dual-energy x-ray absorptiometry with lateral x-ray in assessing vertebral fractures.
The Bone Health TeleECHO Clinic helps telementor healthcare professionals and improves osteoporosis care in underserved communities.
Testosterone treatment improved both bone mineral density and strength in older men.
Researchers found that female patients recovering from critical illness respond better to anti-fracture therapy for bone mineral density loss prevention compared with men.
Study examines the predictive value for vertebral fractures of bone mineral density and bone turnover markers after a 5-year drug holiday.
The risk of developing fracture in postmenopausal women with osteoporosis who discontinued bisphosphonate therapy was evaluated in a retrospective study.
Researchers examined the nonvertebral fracture risk in adults with obesity who underwent Roux-en-Y gastric bypass vs adjustable gastric banding.
Incident falls were linked with total testosterone and bioavailable levels of testosterone after adjusting for age and prevalent falls.
Two distinct time trends were observed in initiation of oral bisphosphonates in women after the 2008 updated osteoporosis treatment guidelines.
Younger survivors of thyroid cancer are at increased risk for certain types of health problems later in life.
Patients with psoriatic arthritis or psoriasis had an increased prevalence of osteoporosis risk factors.
Bone Index announced that the Food and Drug Administration (FDA) has granted clearance for the second generation Bindex device model to aid in the diagnosis of osteoporosis.
A prospective cohort study in 66 patients with end-stage renal disease was conducted to determine the link between renal and coronary heart diseases.
The association between risk for hip fracture and diabetes was attenuated after accounting for mortality risk.
For patients with type 2 diabetes, long-term use of dipeptidyl peptidase-4 (DPP-4) inhibitors is not associated with fracture risk.
Lorraine Fitzpatrick, MD, discusses updated results from the ACTIVE phase 3 clinical trial.
In this week's Handoff, read more about recent FDA approvals, food banks' efforts to improve the healthiness of their donations, and more.
Researchers compared 3 classes of antihypertensive medication to determine hip and pelvic fracture risk in users vs nonusers.
The use of menopausal hormone therapy was associated with improved bone mineral density and better bone microarchitecture.
Nancy E. Lane, MD, professor of medicine, at the University of California at Davis School of Medicine, discusses results from the phase 3 ACTIVE trial.
Heavy cannabis users have lower bone density compared to cigarette smokers.
Calorie restriction has been shown to increase longevity, but it may also have adverse effects on bone health in postmenopausal women.
Summer levels of serum 25-hydroxyvitamin D are associated with bone mineral density of the total hip.
The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) announced the publication of new clinical guidelines and an accompanying algorithm to help physicians and other health care professionals with the diagnosis, fracture risk assessment, and treatment of postmenopausal osteoporosis.
Endocrinology Advisor Articles
- Gestational Diabetes Risk May Be Reduced With Probiotics
- Type 2 Diabetes Therapy Intensification: Part I: Insulin vs GLP-1 Agonists
- American Association of Clinical Endocrinologists 2017 Meeting Preview
- Driving Risk Assessment for Patients With Type 1 Diabetes
- Type 2 Diabetes Therapy Intensification: Part II: GLP-1 Agonist Adverse Effects and Fixed-Ratio Combinations
- Achieving Low HbA1c Levels Benefited Metformin Initiators
- Gestational Diabetes Incidence Did Not Decrease With Inositol Therapy
- Functional Hypothalamic Amenorrhea Diagnosis and Treatment Guidelines Released
- Anticholinergic Medications May Increase Dementia Risk in Diabetes
- Metabolic Syndrome Rates Differ by Race, Ethnicity in Women With Polycystic Ovary Syndrome